The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
出版年份 2017 全文链接
标题
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
作者
关键词
HER2/neu, Gastric cancer, Prognosis, Meta
出版物
World Journal of Surgical Oncology
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-03-21
DOI
10.1186/s12957-017-1132-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of c-erbB-2 Protein on 5-year Survival Rate of Gastric Cancer Patients after Surgery: A Cohort Study and Meta-analysis
- (2017) Hao Wu et al. TUMORI
- Impact of c-erbB-2 Protein on 5-year Survival Rate of Gastric Cancer Patients after Surgery: A Cohort Study and Meta-analysis
- (2017) Hao Wu et al. TUMORI JOURNAL
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma
- (2015) Seyed-Hamid Madani et al. Asian Pacific Journal of Cancer Prevention
- Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections
- (2015) Renato Santos Laboissiere et al. BMC GASTROENTEROLOGY
- A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
- (2015) Domenico Ciliberto et al. CANCER BIOLOGY & THERAPY
- Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy
- (2015) Yasuhiro Mitsui et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study
- (2015) Young Saing Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)
- (2015) Satoshi Matsusaka et al. Gastric Cancer
- Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival
- (2015) Xiao Xiao He et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis
- (2015) Yongjia Yan et al. Clinics and Research in Hepatology and Gastroenterology
- Meta-analysis of Six Randomized Control Trials of Chemotherapy Plus Anti-HER Monoclonal Antibody for Advanced Gastric and Gastroesophageal Cancer
- (2014) Huai-Qing Luo et al. Asian Pacific Journal of Cancer Prevention
- Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
- (2014) Miaozhen Qiu et al. BMC CANCER
- Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
- (2014) Y Kurokawa et al. BRITISH JOURNAL OF CANCER
- HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)
- (2014) Tomohiro Matsumoto et al. Gastric Cancer
- Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer
- (2014) Yukinori Kurokawa et al. Gastric Cancer
- TFF3 and HER2 expression and their correlation with survival in gastric cancer
- (2014) Jianchun Gu et al. TUMOR BIOLOGY
- Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative Resection
- (2014) Ho Sung Son et al. Journal of Gastric Cancer
- HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
- (2013) Ling Shan et al. Diagnostic Pathology
- Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population
- (2013) Masaki Aizawa et al. Gastric Cancer
- Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
- (2013) Yiting Geng et al. International Journal of Clinical Oncology
- HER2 in Gastric Cancer: An Immunohistochemical Study on Tissue Microarrays and the Coressponding Whole-Tissue Sections with a Supplemental Fish Study
- (2013) Gorana Gasljevic et al. PATHOLOGY & ONCOLOGY RESEARCH
- Human epidermal growth factor receptor 2 (Her-2) and S-1 adjuvant chemotherapy in stage 2/3 gastric cancer patients who underwent D2 gastrectomy
- (2013) Toru Aoyama et al. SURGERY TODAY
- Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population
- (2013) Xiang-Shan Fan WORLD JOURNAL OF GASTROENTEROLOGY
- Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer
- (2013) Chao He WORLD JOURNAL OF GASTROENTEROLOGY
- Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
- (2012) Y. Y. Janjigian et al. ANNALS OF ONCOLOGY
- A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages
- (2012) Junhun Cho et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer
- (2012) Muharrem Bayrak et al. Clinical & Translational Oncology
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
- (2012) M. Terashima et al. CLINICAL CANCER RESEARCH
- Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis
- (2012) Hai-Zhen Dang WORLD JOURNAL OF GASTROENTEROLOGY
- Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
- (2012) Fei Zhou et al. World Journal of Surgical Oncology
- Evaluation of HER2 Protein Expression in Gastric Carcinomas: Comparative Analysis of 1414 Cases of Whole-Tissue Sections and 595 Cases of Tissue Microarrays
- (2011) Kab Choong Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma
- (2011) Shi-Yan Yan WORLD JOURNAL OF GASTROENTEROLOGY
- HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
- (2011) Pamela L. Kunz et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain
- (2011) E. U. Cidon et al. Journal of Oncology
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
- (2009) Xiu Li Zhang et al. WORLD JOURNAL OF SURGERY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started